Washington Post (05.07.03) - Wednesday, May 07, 2003
Avram Goldstein

Infection rates among prisoners were dramatically higher than among the general population, based on blood tests of 3,914 people entering the state penal system during a 60-day period in 2002. Hepatitis C was the most prevalent infection in Maryland state prisons, according to the Maryland AIDS Administration's report.

Liza Solomon, the agency's director, said less than 2 percent of the US population is infected with hepatitis C, but 29.7 percent of the Maryland prisoners were infected. The higher rate of disease among prisoners has major public health implications beyond prison walls, she said, because inmates eventually are released into the community, where they can spread the infections. Reaching undiagnosed inmates is an important opportunity for the state to limit diseases that can disrupt or prematurely end lives. Solomon said the study is the first to show systematically that prisoners often have several of the infections simultaneously. Such co-infections are harder to manage, and the symptoms are more severe, she said.

Inmates in Maryland are treated for syphilis and HIV, but the prisons do not routinely give hepatitis B vaccinations, which are highly effective, to inmates or staff members, Solomon said. The prisons offer no routine treatment for inmates with hepatitis C, for which there is no vaccine, she said. The District Health Department's Chief Medical Officer Michael S.A. Richardson said that diagnosing hepatitis C may not be worthwhile because it is not clear that the expensive treatments are effective. "Diagnosing stuff you aren't going to treat is always questionable," Richardson said.

The study also concluded that women entering the Maryland prison system are far more likely than men to be infected with HIV, syphilis and hepatitis C, though not hepatitis B.
030507
AD030921

Copyright © 2003 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.